
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Acrux Limited is a biotechnology business based in Australia. Acrux shares (ACR) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Acrux has a trailing 12-month revenue of around $1.3 million.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | $0.105 - $0.22 |
---|---|
50-day moving average | $0.1853 |
200-day moving average | $0.1777 |
Target price | $0.23 |
PE ratio | N/A |
Dividend yield | $0.06 (33.33%) |
Earnings per share (TTM) | $-0.05 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Revenue TTM | $1.3 million |
---|---|
Gross profit TTM | $-3,759,000 |
Return on assets TTM | -35.72% |
Return on equity TTM | -54.46% |
Profit margin | 0% |
Book value | 0.076 |
Market capitalisation | $50.8 million |
TTM: trailing 12 months
We're not expecting Acrux to pay a dividend over the next 12 months.
Over the last 12 months, Acrux's shares have ranged in value from as little as $0.105 up to $0.22. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Acrux's is 0.909. This would suggest that Acrux's shares are less volatile than average (for this exchange).
Acrux Limited, together with its subsidiaries, develops and commercializes generic and specialty topical pharmaceuticals in Australia, Germany, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. Acrux Limited was founded in 1998 and is based in West Melbourne, Australia.
You can now invest as little as 1 cent into Australian, NZ and US shares. Here's why that's a game changer.
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
All the key info you need to know to sell shares you inherited or received as a gift.
Steps to owning and managing Roblox shares.
Everything we know about the Deliveroo IPO, plus information on how to buy in.
Steps to owning and managing Zebit shares.
Steps to owning and managing CleanSpace shares.
Steps to owning and managing Benz Mining shares.